Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Implementation of population-level screening for frailty among patients admitted to adult intensive care in Alberta, Canada.

Montgomery CL, Zuege DJ, Rolfson DB, Opgenorth D, Hudson D, Stelfox HT, Bagshaw SM.

Can J Anaesth. 2019 Nov;66(11):1310-1319. doi: 10.1007/s12630-019-01414-8. Epub 2019 May 29.

PMID:
31144259
2.

Frailty and the Association Between Long-Term Recovery After Intensive Care Unit Admission.

Montgomery CL, Rolfson DB, Bagshaw SM.

Crit Care Clin. 2018 Oct;34(4):527-547. doi: 10.1016/j.ccc.2018.06.007. Epub 2018 Aug 11. Review.

PMID:
30223992
3.

Quantification of Changes in Visual Function During Disease Development in a Mouse Model of Pigmentary Glaucoma.

Grillo SL, Montgomery CL, Johnson HM, Koulen P.

J Glaucoma. 2018 Sep;27(9):828-841. doi: 10.1097/IJG.0000000000001024.

4.

Mechanisms Underlying Early-Stage Changes in Visual Performance and Retina Function After Experimental Induction of Sustained Dyslipidemia.

Montgomery CL, Johnson HM, Johnston TP, Koulen P.

Neurochem Res. 2018 Aug;43(8):1500-1510. doi: 10.1007/s11064-018-2563-2. Epub 2018 Jun 2.

5.

Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis.

Yalvac ME, Amornvit J, Braganza C, Chen L, Hussain SA, Shontz KM, Montgomery CL, Flanigan KM, Lewis S, Sahenk Z.

Skelet Muscle. 2017 Dec 14;7(1):27. doi: 10.1186/s13395-017-0146-6.

6.

Innovative Urgent Care for the Palliative Patient at Home.

Montgomery CL, Pooler C, Arsenault JE, Berean C, Sharman R, Cameron CL, de Kock I.

Home Healthc Now. 2017 Apr;35(4):196-201. doi: 10.1097/NHH.0000000000000526.

PMID:
28353509
7.

Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma.

Montgomery CL, Keereetaweep J, Johnson HM, Grillo SL, Chapman KD, Koulen P.

Lipids. 2016 Jul;51(7):857-66. doi: 10.1007/s11745-016-4161-x. Epub 2016 May 24.

8.

Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient Mice.

Heller KN, Montgomery CL, Shontz KM, Clark KR, Mendell JR, Rodino-Klapac LR.

Hum Gene Ther. 2015 Oct;26(10):647-56. doi: 10.1089/hum.2015.062. Epub 2015 Aug 11.

9.

AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models.

Sondergaard PC, Griffin DA, Pozsgai ER, Johnson RW, Grose WE, Heller KN, Shontz KM, Montgomery CL, Liu J, Clark KR, Sahenk Z, Mendell JR, Rodino-Klapac LR.

Ann Clin Transl Neurol. 2015 Mar;2(3):256-70. doi: 10.1002/acn3.172. Epub 2015 Jan 20.

10.

Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity.

Faure L, Nagarajan S, Hwang H, Montgomery CL, Khan BR, John G, Koulen P, Blancaflor EB, Chapman KD.

J Biol Chem. 2014 Mar 28;289(13):9340-51. doi: 10.1074/jbc.M113.533315. Epub 2014 Feb 20.

11.

Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.

Chicoine LG, Montgomery CL, Bremer WG, Shontz KM, Griffin DA, Heller KN, Lewis S, Malik V, Grose WE, Shilling CJ, Campbell KJ, Preston TJ, Coley BD, Martin PT, Walker CM, Clark KR, Sahenk Z, Mendell JR, Rodino-Klapac LR.

Mol Ther. 2014 Feb;22(2):338-347. doi: 10.1038/mt.2013.244. Epub 2013 Oct 23.

12.

Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.

Chicoine LG, Rodino-Klapac LR, Shao G, Xu R, Bremer WG, Camboni M, Golden B, Montgomery CL, Shontz K, Heller KN, Griffin DA, Lewis S, Coley BD, Walker CM, Clark KR, Sahenk Z, Mendell JR, Martin PT.

Mol Ther. 2014 Apr;22(4):713-24. doi: 10.1038/mt.2013.246. Epub 2013 Oct 22.

13.

Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.

Rodino-Klapac LR, Janssen PM, Shontz KM, Canan B, Montgomery CL, Griffin D, Heller K, Schmelzer L, Handy C, Clark KR, Sahenk Z, Mendell JR, Kaspar BK.

Hum Mol Genet. 2013 Dec 15;22(24):4929-37. doi: 10.1093/hmg/ddt342. Epub 2013 Jul 17.

14.

AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.

Heller KN, Montgomery CL, Janssen PM, Clark KR, Mendell JR, Rodino-Klapac LR.

Mol Ther. 2013 Mar;21(3):520-5. doi: 10.1038/mt.2012.281. Epub 2013 Jan 15.

15.

Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer.

Grose WE, Clark KR, Griffin D, Malik V, Shontz KM, Montgomery CL, Lewis S, Brown RH Jr, Janssen PM, Mendell JR, Rodino-Klapac LR.

PLoS One. 2012;7(6):e39233. doi: 10.1371/journal.pone.0039233. Epub 2012 Jun 15.

16.

AAV-mediated gene therapy to the isolated limb in rhesus macaques.

Rodino-Klapac LR, Montgomery CL, Mendell JR, Chicoine LG.

Methods Mol Biol. 2011;709:287-98. doi: 10.1007/978-1-61737-982-6_19.

PMID:
21194036
17.

Reversible immobilization of giant otters (Pteronura brasiliensis) using medetomidine-ketamine and atipamezole.

Bauquier SH, Hinshaw KC, Ialeggio DM, Montgomery CL, Perkowski SZ.

J Zoo Wildl Med. 2010 Jun;41(2):346-9.

PMID:
20597232
18.

Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.

Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PM, Clark KR, Sahenk Z, Mendell JR, Kaspar BK.

Sci Transl Med. 2009 Nov 11;1(6):6ra15. doi: 10.1126/scitranslmed.3000112.

19.

Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery.

Rodino-Klapac LR, Montgomery CL, Bremer WG, Shontz KM, Malik V, Davis N, Sprinkle S, Campbell KJ, Sahenk Z, Clark KR, Walker CM, Mendell JR, Chicoine LG.

Mol Ther. 2010 Jan;18(1):109-17. doi: 10.1038/mt.2009.254. Epub 2009 Nov 10.

20.

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT.

Cell. 2009 Jun 12;137(6):1005-17. doi: 10.1016/j.cell.2009.04.021.

21.

Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.

Martin PT, Xu R, Rodino-Klapac LR, Oglesbay E, Camboni M, Montgomery CL, Shontz K, Chicoine LG, Clark KR, Sahenk Z, Mendell JR, Janssen PM.

Am J Physiol Cell Physiol. 2009 Mar;296(3):C476-88. doi: 10.1152/ajpcell.00456.2008. Epub 2008 Dec 24.

22.

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK.

Nat Biotechnol. 2009 Jan;27(1):59-65. doi: 10.1038/nbt.1515. Epub 2008 Dec 21.

23.

A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.

Rodino-Klapac LR, Janssen PM, Montgomery CL, Coley BD, Chicoine LG, Clark KR, Mendell JR.

J Transl Med. 2007 Sep 24;5:45.

24.
25.

Problem-Based Learning in Anesthesiology: An Evaluative Study of a Medical Student Clerkship.

Musick DW, Montgomery CL, Pedigo NW.

J Educ Perioper Med. 1999 May 1;1(2):E005. eCollection 1999 May-Aug.

26.

Coping with the emotional demands of caring.

Montgomery CL.

Adv Pract Nurs Q. 1997 Summer;3(1):76-84.

PMID:
9485784
27.

A course in advanced clinical pharmacology and anesthesiology.

Montgomery CL, Bonaminio GA, Pedigo NW Jr.

Acad Med. 1996 May;71(5):541. No abstract available.

PMID:
10676280
28.

The care-giving relationship: paradoxical and transcendent aspects.

Montgomery CL.

Altern Ther Health Med. 1996 Mar;2(2):52-7. No abstract available.

PMID:
8795889
29.

A prospective study of rectal methohexital: efficacy and side effects in 648 cases.

Audenaert SM, Montgomery CL, Thompson DE, Sutherland J.

Anesth Analg. 1995 Nov;81(5):957-61.

PMID:
7486084
30.

Cardiorespiratory effects of premedication for children.

Audenaert SM, Wagner Y, Montgomery CL, Lock RL, Colclough G, Kuhn RJ, Johnson GL, Pedigo NW Jr.

Anesth Analg. 1995 Mar;80(3):506-10.

PMID:
7864415
31.

Caring, curing, and brief therapy: a model for nurse-psychotherapy.

Montgomery CL, Webster D.

Arch Psychiatr Nurs. 1994 Oct;8(5):291-7. Review.

PMID:
7993130
32.

Physician retraining, lifelong learning, and the library.

Moore M, Van Schaik J, Montgomery CL.

Bull Med Libr Assoc. 1992 Oct;80(4):374-6. No abstract available.

33.

The spiritual connection: nurses' perceptions of the experience of caring.

Montgomery CL.

NLN Publ. 1992 Apr;(15-2465):39-52. No abstract available.

PMID:
1494481
34.

Retrograde-assisted fiberoptic tracheal intubation in children with difficult airways.

Audenaert SM, Montgomery CL, Stone B, Akins RE, Lock RL.

Anesth Analg. 1991 Nov;73(5):660-4. No abstract available.

PMID:
1952153
35.

Application of the Mizus endotracheal obturator in tracheostomy and tentative extubation.

Audenaert SM, Montgomery CL, Slayton D, Berger R.

J Clin Anesth. 1991 Sep-Oct;3(5):418-21.

PMID:
1931069
36.

Patients are more than customers.

Montgomery CL.

Am J Nurs. 1988 Sep;88(9):1257-8. No abstract available.

PMID:
3414763
37.

The hospital employee as patient.

Montgomery CL.

Am J Nurs. 1987 Dec;87(12):1687. No abstract available.

PMID:
3688059
38.

Make the time and you can make a difference.

Montgomery CL.

J Ark Med Soc. 1987 Nov;84(6):253. No abstract available.

PMID:
2961730
39.

Battling the awfulistic, absolutist 'shoulds'.

Montgomery CL.

Am J Nurs. 1987 Jun;87(6):859-60. No abstract available.

PMID:
3647731
40.

How to set limits when a patient demands too much.

Montgomery CL.

Am J Nurs. 1987 Mar;87(3):365-6. No abstract available.

PMID:
3644601
41.

Taming a tyrant.

Montgomery CL.

Am J Nurs. 1987 Feb;87(2):234, 238. No abstract available.

PMID:
3643764
42.

In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.

Horadam VW, Smilack JD, Montgomery CL, Werringloer J.

Antimicrob Agents Chemother. 1980 Oct;18(4):557-61.

Supplemental Content

Loading ...
Support Center